Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Iambic maintains momentum from string of Big Pharma partnerships by aiming for IPO

Iambic maintains momentum from string of Big Pharma partnerships by aiming for IPO

September 22, 2026Posted inBiotechnology

Iambic Therapeutics is maintaining the momentum generated by its recent megaround and Big Pharma partnerships by gearing up to go public.

Post navigation

Previous Post
leopard-genomics-paper-on-south-africa’s-cape-floristic-region-retracted Leopard Genomics Paper on South Africa’s Cape Floristic Region Retracted
Next Post
Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes

Recent Posts

  • Roche’s GLP-1/GIP drug hits in phase 2 diabetes trial, fueling best-in-disease hopes
  • Iambic maintains momentum from string of Big Pharma partnerships by aiming for IPO
  • Leopard Genomics Paper on South Africa’s Cape Floristic Region Retracted
  • AI Learns to Forget: New Hypernetwork Framework Enables Data-Free Unlearning
  • SARS-CoV-2 Protein Fuels Lung Inflammation by Hijacking Macrophages

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top